Can MRD Guide Better CLL Treatment With Sonrotoclax? | Marc Hoffmann, MD

New SEQUOIA Trial Results Shake Up First‑Line CLL Care! | Amit Agarwal, MD, PhD

Non-Covalent vs Covalent BTK Inhibitors: What’s Best of Patients | Jennifer Woyach, MD

Is Time-Limited Therapy the Future for CLL? | Romain Guieze, MD

Is Rocbrutinib a New Option for CLL Patients? Phase 1 Trial Updates | Jennifer Woyach, MD

Is 1-Year Therapy Just as Effective as Multiple Years? | Othman Al-Sawaf, MD

Mosunetuzumab: A Potential Option for Frail DLBCL Patients | Jeff Sharman, MD

Ibrutinib + Venetoclax (I+V) for CLL: Findings from CAPTIVATE & GLOW | Paolo Ghia, MD, PhD

Optimal 2nd-Line Treatment for CLL? GAIA/CLL13 Findings | Carsten Niemann, MD

BETA - What is some of the most promising research being done to treat chronic lymphocytic leukemia?

BETA - What tests will I need to do for my chronic lymphocytic leukemia and how often?

BETA - Who is the best person to treat my chronic lymphocytic leukemia?

BETA - How do I know the stage of my chronic lymphocytic leukemia?

BETA - How is chronic lymphocytic leukemia diagnosed?

BETA - Is my family at risk of developing chronic lymphocytic leukemia?

BETA - How prevalent is chronic lymphocytic leukemia in the US?

BETA - Is there a cure for chronic lymphocytic leukemia?